|
MechanismGnRHR antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date08 Jan 2019 |
Target- |
Mechanism- |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Switzerland |
First Approval Date16 Oct 2009 |
|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date11 Apr 2002 |
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Parallel-Group Phase II/III Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablets for Postoperative Analgesia in Abdominal Surgery
This clinical trial is a multiple-center, randomized, double-blind, placebo- and active-controlled parallel-group Phase II/III clinical trial, to evaluate the efficacy and safety of HL-1186 Tablets for Postoperative Analgesia in Abdominal Surgery.
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Parallel-Group Phase II/III Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablets for Postoperative Analgesia in Orthopedic Surgery
This clinical trial is a multiple-center, randomized, double-blind, placebo- and active-controlled parallel-group Phase II/III clinical trial, to evaluate the efficacy and safety of HL-1186 Tablets for Postoperative Analgesia in Orthopedic Surgery.
[Translation] H062 tablets human relative bioavailability test
以沙库巴曲缬沙坦钠片和苯磺酸氨氯地平片为对照,评价H062片在健康人体内的相对生物利用度和安全性。
[Translation] Using sacubitril/valsartan sodium tablets and amlodipine besylate tablets as controls, the relative bioavailability and safety of H062 tablets in healthy human subjects were evaluated.
100 Clinical Results associated with Shanghai Huilun Life Science & Technology Co. Ltd.
0 Patents (Medical) associated with Shanghai Huilun Life Science & Technology Co. Ltd.
100 Deals associated with Shanghai Huilun Life Science & Technology Co. Ltd.
100 Translational Medicine associated with Shanghai Huilun Life Science & Technology Co. Ltd.